Albert Einstein College of Medicine receives SU2C grant for cancers research Matthew Levy.

While the immediate focus shall be on prostate cancer, the systems developed will end up being broadly applicable to many other cancers. Dr. Levy’s attempts will center on aptamers, a newer class of targeting molecule that can particularly bind to particular proteins on the surface of cancer cells. The aptamers will be coupled with existing FDA-approved medications then, creating an individual molecule called an aptamer-prodrug. Upon binding with their target, these aptamer-prodrugs will launch the drug cargo into the cell directly, minimizing systemic toxicity thereby.Related StoriesARC Telehealth System allows fertility individuals connect with medical professionals through mobile devicesSame-sex couples encounter even more obstacles to infertility treatment in comparison to opposite-sex couplesStudy explores performance of frontline remedies for couples with unexplained infertilityThe paid survey gauged knowing of embryo donation in advance of embryo donation recognition workshops hosted by RESOLVE on Saturday, September 12, 2009, in the Washington, D.C. Suburb of McLean, VA. At the free of charge workshops, couples and individuals will be released to the medical, mental and legal medical issues surrounding embryo donation, a relatively new process in which individuals who’ve undergone in-vitro fertilization treatment and have extra frozen embryos decide to release the embryos for transfer to the uterus of another woman.3 million Americans are struggling with infertility.